Biopharma industry leaders embrace AI-driven lab-in-the-loop workflows to consolidate compound design, ADME profiling, and compound management into unified, digitally enabled drug discovery pipelines. Ginkgo Bioworks collaborates with Inductive Bio and Tangible Scientific to streamline iterative design cycles, accelerating experimental feedback and reducing costs. Similarly, Sanofi’s iCMC Digital Transformation Program speeds development via deep learning and in silico modeling, marking a transition toward predictive, automated bioprocessing that enhances efficiency and facilitates innovation.